OMCL - Rasio rega marang prakiraan pendapatan Omnicell Health

omnicell.com - logo grafis emiten OMCL

Omnicell, Inc. (OMCL) is currently focusing on internal updates and organic growth following a period of active mergers. Competent management aims to restore sales momentum, as confirmed by the forward P/S trend on GURU.Markets, where the 0.60 mark records this metric. Operational efficiency is maintained by outsourcing equipment production and services to third-party contractors.

OMCL (omnicell.com) riwayat Rega forward marang dodolan saka 04.07.2022 nganti 13.11.2026

Omnicell Health - rincian analitis lan metrik utama (OMCL)

- rega pasar lan target rega analis:
Analisis kabeh metrik perusahaan:Omnicell (OMCL)
Produk asli Omnicell Health

For Omnicell, Inc. (OMCL), business valuation relative to future revenue streams is critical due to its dependence on government procurement cycles. The forward P/S multiple compares current market capitalization with expected sales volume. This chart reflects the market's reassessment of risks associated with delays in hospital system modernization and the implementation of cloud services. A decline in this metric may indicate either an undervalued asset or a systemic slump in demand.

Analisis perusahaan pesaing

Rasio rega marang prakiraan pendapatan Veeva VEEV|Doximity Inc - Rasio rega marang prakiraan pendapatan|HQY - Rasio rega marang prakiraan pendapatan|WAY: Rasio rega marang prakiraan pendapatan|CRVL (CorVel Corporation) - Multiplikator forward rega marang pendapatan|priviahealth.com - Rega forward marang dodolan|HURN (Huron) - Multiplikator Forward P/S|Certara Inc (CERT) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan GoodRx Corp (GDRX)|Schrodinger Corp - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S PHR (Phreesia, Inc.)|OMDA - Multiplikator forward rega marang pendapatan|EVH: Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake HealthStream Inc HSTM|Definitive Healthcare Inc. (DH) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Consensus Corp (CCSI)|Rasio rega marang prakiraan pendapatan Agilon Health|Multiplikator forward rega marang pendapatan absci.com (ABSI)|Multiplikator Forward P/S SY|Multiplikator forward rega marang pendapatan NRC Health NRC|Rasio rega marang prakiraan pendapatan Spok Corp SPOK|OptimizeRx Inc. - Rasio rega marang prakiraan pendapatan|TruBridge, Inc. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake simulations-plus.com SLP|SOPH (sophiagenetics.com) - Multiplikator forward rega marang pendapatan|HCAT: Rasio rega marang pendapatan sing dikarepake|Multiplikator forward rega marang pendapatan CCLD|RSSS: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan DLH Holdings Corp. (DLHC)|Multiplikator forward rega marang pendapatan onemednet.com ONMD|Multiplikator Forward P/S SCNX (Scienture)|Healthcare Triangle Inc (HCTI) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|iSpecimen Corp - Multiplikator Forward P/S|BFRG (Bullfrog AI Holdings) - Kapitalisasi marang prakiraan pendapatan|SCWorx Corp. (WORX) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep msprecovery.com (MSPR)|Rasio rega marang prakiraan pendapatan iCoreConnect, Inc.|Multiplikator forward rega marang pendapatan TRxADE HEALTH Inc (MEDS)|Rasio rega marang prakiraan pendapatan Orgenesis Corp (ORGS)|r1rcm.com - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S SHCR (Sharecare, Inc.)|Rasio kapitalisasi marang dodolan sing dikarepake streamlinehealth.net (STRM)|Syra Health - Multiplikator Forward P/S|Apollo Medical Holdings (AMEH) - Multiplikator forward rega marang pendapatan|MODN: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep NextGen Healthcare Corp (NXGN)